Loading
An early trial studying the safety and activity of experimental treatment. Its registry status does not establish patient benefit.
A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors. ClinicalTrials.gov record last updated 2025-07-17: recruiting. Enrollment is planned at 48 participants. Primary completion is estimated at 2026-11-05. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/